Post-earnings recap
Reported
Thu, Jan 29, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
0%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Dr. Reddy's Laboratories reported an EPS of $0.53, but revenue figures were not disclosed. The stock reacted positively, rising by 2.96%. Investors may be optimistic despite the lack of revenue data, possibly reflecting confidence in the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.53 | N/A | — |
| Revenue | N/A | N/A | — |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.